NIPPON PAINT HOLDINGS rebounds for first time in three sessions as domestic brokerage raises target price to 1,550 yen
NIPPON PAINT HOLDINGS CO., LTD. <4612> rebounded for the first time in three sessions after SMBC Nikko Securities raised its price target on the stock to 1,550 yen from 1,400 yen on the 2nd. The brokerage maintained its top rating of 1 on a three-tier scale.
Following second-quarter earnings, SMBC Nikko confirmed continued strong performance in segments outside NIPSEA China and said it is focusing on NIPPON PAINT's growth trajectory independent of China.
The brokerage trimmed its consolidated operating profit forecast for the fiscal year ending December 2026 to 284.0 billion yen from 287.0 billion yen, compared with NIPPON PAINT's guidance of 283.0 billion yen. However, it raised its forecast for the fiscal year ending December 2027 to 315.0 billion yen from 310.0 billion yen.
SMBC Nikko said NIPPON PAINT's current valuation, well below its historical average, underestimates its competitive strengths.
Source: MINKABU PRESS
*Translated by generative AI. Click here for the original article.
Related Articles
-
SAC'S BAR moves little after August same-store sales show continued positive trend
Thu Sep 3, 2026 2:04 pm JST Catalyst -
TAKEBISHI rebounds on plan to make Fukui Mitsubishi Electric Kiki Hanbai a subsidiary
Thu Sep 3, 2026 1:58 pm JST Catalyst -
ULVAC rebounds for first time in four sessions after Eastspring Investments discloses stake of over 6%
Thu Sep 3, 2026 2:18 pm JST Catalyst -
Lasertec gains in afternoon session as optimism grows over EUV lithography development race
Thu Sep 3, 2026 2:09 pm JST Catalyst -
Market breadth at 2 p.m.: 954 gainers vs. 538 decliners on TSE Prime
Thu Sep 3, 2026 2:04 pm JST Market -
INPEX extends losses as WTI crude briefly falls below $91 in after-hours trading
Thu Sep 3, 2026 1:39 pm JST Catalyst -
unbanked ranks 5th in 'rising buy forecasts' among individual investors on Minkabu
Thu Sep 3, 2026 1:35 pm JST Catalyst -
ASAHI extends losses as August same-store sales fall for second straight month
Thu Sep 3, 2026 1:29 pm JST Catalyst -
Eisai rebounds after lecanemab subcutaneous formulation approved in China as initial therapy for early AD
Thu Sep 3, 2026 1:26 pm JST Catalyst -
Market breadth at 1 p.m.: 978 gainers vs. 509 decliners on TSE Prime
Thu Sep 3, 2026 1:04 pm JST Market